At 16.7x earnings with a Forward P/E of 8.9, BMO screens as materially cheaper on forward expectations, implying a sharp earnings ramp toward the $8.63 EPS estimate next year. A PEG Forward of 1 suggests the valuation is aligned with growth rather than stretched, and a 3.2% TTM yield compensates investors while they wait. However, the absence of an Altman Z-Score and a modest 4.30% Return on Equity temper the enthusiasm — this is not a high-efficiency compounder today, but the forward multiple compression suggests the market may be underpricing a cyclical earnings normalization rather than structural decay. Overall, the setup leans toward undervalued with improving forward optics, but not without balance sheet sensitivity.